Crescent Capital BDC (NASDAQ:CCAP) Coverage Initiated at LADENBURG THALM/SH SH

Analysts at LADENBURG THALM/SH SH assumed coverage on shares of Crescent Capital BDC (NASDAQ:CCAP) in a research report issued on Monday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $20.00 price target on the stock. LADENBURG THALM/SH SH’s target price would suggest a potential upside of 9.77% from the company’s current price.

A number of other research firms also recently commented on CCAP. Bank of America cut their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 15th. Wells Fargo & Company lowered their price objective on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 14th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Crescent Capital BDC has a consensus rating of “Moderate Buy” and an average target price of $19.00.

Crescent Capital BDC Trading Down 1.5 %

NASDAQ:CCAP opened at $18.22 on Monday. The stock has a fifty day moving average price of $18.36 and a two-hundred day moving average price of $18.17. The stock has a market capitalization of $675.27 million, a price-to-earnings ratio of 6.48 and a beta of 0.81. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.40 and a current ratio of 1.40. Crescent Capital BDC has a 1 year low of $15.03 and a 1 year high of $19.63.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings data on Monday, August 12th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. The business had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. During the same quarter last year, the company earned $0.56 earnings per share. As a group, sell-side analysts anticipate that Crescent Capital BDC will post 2.34 earnings per share for the current fiscal year.

Institutional Trading of Crescent Capital BDC

Several hedge funds have recently added to or reduced their stakes in the business. Point72 Asset Management L.P. acquired a new position in Crescent Capital BDC during the 2nd quarter valued at $90,000. Tucker Asset Management LLC acquired a new stake in Crescent Capital BDC during the 4th quarter worth $167,000. XTX Topco Ltd bought a new position in shares of Crescent Capital BDC during the second quarter worth $195,000. Alpine Global Management LLC bought a new stake in Crescent Capital BDC in the 1st quarter valued at $217,000. Finally, Catalina Capital Group LLC bought a new stake in Crescent Capital BDC in the 2nd quarter valued at $220,000. Institutional investors own 49.46% of the company’s stock.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.